1. Home
  2. AQST

as 05-30-2025 12:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Founded: 2004 Country:
United States
United States
Employees: N/A City: WARREN
Market Cap: 272.9M IPO Year: 2018
Target Price: $11.40 AVG Volume (30 days): 1.8M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.59 EPS Growth: N/A
52 Week Low/High: $2.12 - $5.80 Next Earning Date: 05-12-2025
Revenue: $54,228,000 Revenue Growth: 5.29%
Revenue Growth (this year): -18.55% Revenue Growth (next year): 40.62%

AQST Daily Stock ML Predictions

Share on Social Networks: